Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Menarini Licenses Obicetrapib from NewAmsterdam Pharma (2022-06-28)
-- Combines NewAmsterdam’s lead clinical program obicetrapib with Menarini’s deep cardiovascular disease and regional expertise -- -- Total deal value of over €1 billion; including €142.5 million upfront payment and committed R&D funding plus potential mileston...
Biotalys & Novozymes Partner to Advance Biocontrol Evoca (2022-06-21)
Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, and Novozymes, a world leader in biotech solutions, today announced that the companies have entered into a partnership to expa...
Galapagos Acquires Cell Therapy Firms CellPoint & AboundBio (2022-06-21)
> Potential for paradigm shift in CAR-T therapy with CellPoint’s decentralized point-of-care manufacturing model, in partnership with Lonza, and AboundBio’s cutting-edge fully human antibody-based capabilities, providing a platform of next-generation CAR-Ts and bis...
Knauer Acquires Dutch Lab Automation Firm ModuVision (2022-06-21)
This year KNAUER is celebrating the 60th company anniversary and there is more reason for joy. The management is excited to announce that KNAUER has just taken an important step. They aquired a company based in Vlissingen in the Netherlands. This hightech company i...
Genomatica & Unilever Launch $120m Joint Venture (2022-06-16)
> Using Geno’s cutting-edge biotechnology, the venture aims to commercialize and scale plant-based alternatives to feedstocks like palm oil or fossil fuels, to make key ingredients used in everyday cleaning and personal care products. > Unilever’s investment, ...
Gimv Creates Dedicated Life Sciences VC Platform (2022-06-15)
> Carve-out of new Life Sciences platform from Gimv’s existing Healthcare platform > Builds on Gimv’s more than 40 years’ experience of successful investment in the sector > Ambition to grow the life sciences VC portfolio to around 20 companies, from 12 today...
Evotec Enters a Drug Discovery Collaboration with Janssen (2022-06-14)
STRATEGIC PARTNERSHIP LEVERAGES EVOTEC’S PROPRIETARY PLATFORM CAPABILITIES IN THE FIELD OF PROTEIN HOMEOSTASIS Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered a drug discovery...
HTGF’s Fourth Fund Announces First Closing at over €400m (2022-06-14)
> High-Tech Gründerfonds’ fourth fund has already secured more than €400 million in commitments at first closing. > The volume of investment committed has clearly surpassed expectations. Second closing is scheduled to take place later this year. > Forty priva...
ImCheck Closes €80m Series C Led by Earlybird & Andera (2022-06-13)
> Significant round will enable the Company to advance ICT01, its lead anti-butyrophilin 3A antibody, to completion of randomized Phase II trials > Series C adds global investors Earlybird, Andera Partners, Invus and patient organization The Leukemia & Lymphoma ...
CimCure Raises €5m Seed Round Led by Positron Ventures (2022-06-10)
> Positive results of effectiveness in dogs of the iBoost vaccine-based cancer immunotherapy published in Nature Communications > Seed round led by Positron Ventures, supported by several health investors including Amsterdam UMC professor and biotech investor To...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)